Skip to main content

Table 1 Baseline demographics and clinical characteristics of the study patients and controls

From: Brain MRI morphometric analysis in Parkinson’s disease patients with sleep disturbances

Characteristic

Parkinson’s disease patients

Controls

P valuea

Age (years)

58 [55–63]

55 [49–65]

0.15

Male/Female (number)

14/14

14/14

0.78

Levodopa dosage equivalence mg

600[400–785]

 

UPDRS – III (score)

18[12–21]

 

MMSE (score)

28[26–29]

29[27–30]

0.15b

PDSS (score) overall

81.3[64.4–109.9]

 
  1. aPearson test unless otherwise specified
  2. bSpearman test
  3. Values expressed in median [IQR] or number
  4. UPDRS-III Unified Parkinson’s Disease Rating Scale, Motor Part III
  5. MMSE mini-metal state examination
  6. PDSS Parkinson disease sleep scale